Poseida Therapeutics, Inc. (PSTX) has 27 open-market insider trades by 7 insiders since 2014. The most active filer is Eric Ostertag, Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Malin Life Sciences Holdings Ltd | 10% Owner | — | 6 | $14.6M | 2025-01-08 |
| Eric Ostertag | Chairman | — | 15 | $8.4M | 2023-02-01 |
| Stephen J. Clearman | 10% | — | 1 | $4.2M | 2014-01-10 |
| David Hirsch | Dir | — | 1 | $4.0M | 2020-07-14 |
| Marcea Bland Lloyd | Dir | — | 1 | $160K | 2025-01-08 |
| Sean Murphy | Dir10% Owner | — | 1 | $160K | 2020-07-14 |
| Kerry D. Ingalls | COO | — | 2 | $26K | 2022-03-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark J. Gergen | Chairman | Sell | $284K | 2024-12-10 |
| Mark J. Gergen | Chairman | Sell | $278K | 2024-11-26 |
| Malin Life Sciences Holdings Ltd | 10% Owner | Buy | $7.5M | 2022-08-08 |
| Eric Ostertag | Chairman | Buy | $1000K | 2022-08-08 |
| Eric Ostertag | Chairman | Sell | $1.2M | 2022-08-03 |
| Kerry D. Ingalls | COO | Buy | $12K | 2022-03-16 |
Companies that share insiders with PSTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Malin Life Sciences Holdings Ltd | 10% | Buy | $13K | 2021-12-06 |
| Malin Life Sciences Holdings Ltd | 10% Owner | Buy | $673K | 2021-11-30 |
| Malin Life Sciences Holdings Ltd | 10% Owner | Buy | $531K | 2021-11-24 |
| Malin Life Sciences Holdings Ltd | 10% Owner | Buy | $363K | 2021-11-19 |
| Kerry D. Ingalls | COO | Buy | $14K | 2021-11-17 |
| Malin Life Sciences Holdings Ltd | 10% Owner | Buy | $5.5M | 2021-11-16 |
| Eric Ostertag | CEO | Sell | $268K | 2021-11-08 |
| Eric Ostertag | CEO | Sell | $208K | 2021-10-01 |
| Eric Ostertag | CEO | Sell | $160K | 2021-09-20 |